Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AXNX vs $CTSO | Chartloom

Compare

$AXNX vs $CTSO

Axonics Inc · Cytosorbents Corp

AXNX

Axonics Inc

CTSO

Cytosorbents Corp

Compare $AXNX vs $CTSO

Comparing Axonics Inc and Cytosorbents Corp

AXNXAxonics Inc

CTSOCytosorbents Corp

AXNXAxonics Inc

Market cap

$36M

P/E (TTM)

—

Forward P/E (NTM)

1.40x

Forward P/S (NTM)

0.07x

Rev growth (TTM)

26.1%

YTD performance

-0.1%

52W performance

-98.8%

FCF yield

14.8%

CTSOCytosorbents Corp

Market cap

$217M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.02x

Rev growth (TTM)

8.6%

YTD performance

-73.6%

52W performance

-81.1%

FCF yield

-4.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AXNX

CTSO

Not enough overlapping price history for this window.

Detailed metrics comparison

AXNX

Axonics Inc

CTSO

Cytosorbents Corp

Market Cap

AXNX$36M

CTSO$217M

Enterprise Value

AXNX$-203M

CTSO$230M

Price

AXNX$0.71

CTSO$3.46

P/E Ratio

AXNXN/A

CTSON/A

P/S Ratio

AXNX0.08x

CTSO5.84x

EV/Sales

AXNX-0.47x

CTSO6.19x

EV/EBITDA

AXNX-58.64x

CTSO0.00x

P/B Ratio

AXNX0.02x

CTSO5.44x

P/FCF Ratio

AXNX6.75x

CTSON/A

EV/FCF

AXNX-37.80x

CTSO-23.75x

PEG Ratio

AXNXN/A

CTSON/A

Forward P/E (NTM)

AXNX1.40x

CTSON/A

Forward P/S (NTM)

AXNX0.07x

CTSO5.02x

Revenue (TTM)

AXNX$432M

CTSO$37M

Revenue Growth (YoY)

AXNX26.1%

CTSO8.6%

Forward Rev Growth

AXNX0.0%

CTSO13.6%

Gross Margin (TTM)

AXNX76.6%

CTSO71.6%

Operating Margin (TTM)

AXNX0.0%

CTSO0.0%

EBITDA Margin (TTM)

AXNX1.2%

CTSO-28.3%

Net Margin (TTM)

AXNX-1.3%

CTSO-48.9%

FCF Margin (TTM)

AXNX1.2%

CTSO-26.0%

Net Income (TTM)

AXNX$-6M

CTSO$-18M

FCF (TTM)

AXNX$5M

CTSO$-10M

EPS (TTM)

AXNX-$0.11

CTSO-$0.29

ROE (TTM)

AXNX-88.0%

CTSO-16513.0%

ROA (TTM)

AXNX-77.0%

CTSO-4325.0%

ROIC (TTM)

AXNX-88.0%

CTSO-5193.0%

Cash

AXNX$239M

CTSO$4M

Debt

AXNX$0

CTSO$17M

Net Cash/Debt

AXNX$239M

CTSO$-13M

Current Ratio (TTM)

AXNX8.16x

CTSO0.66x

Quick Ratio (TTM)

AXNX6.33x

CTSO0.47x

Debt/Equity (TTM)

AXNX0.00x

CTSO7.73x

Debt/Assets (TTM)

AXNX0.0%

CTSO0.0%

Interest Coverage (TTM)

AXNXN/A

CTSON/A

Net Debt/EBITDA (TTM)

AXNX0.00x

CTSO0.00x

Beta

AXNX3.24

CTSO1.51

52W Performance

AXNX-98.8%

CTSO-81.1%

YTD Performance

AXNX-0.1%

CTSO-73.6%

% from 52W High

AXNX-99.0%

CTSO-82.5%

% from 52W Low

AXNX1.4%

CTSO1.1%

Asset Turnover (TTM)

AXNX0.58x

CTSO0.88x

FCF Yield (TTM)

AXNX14.8%

CTSO-4.5%

Earnings Yield (TTM)

AXNX-15.6%

CTSO-8.4%

Dividend Yield (TTM)

AXNXN/A

CTSON/A

Rule of 40

AXNX27.3

CTSO-17.4

EV/GP/RG

AXNXN/A

CTSO0.53

Ticker research

View AXNX research View CTSO research

Metric	AXNX Axonics Inc	CTSO Cytosorbents Corp
Market & Valuation
Market Cap	$36M	$217M
Enterprise Value	$-203M	$230M
Price	$0.71	$3.46
P/E Ratio	N/A	N/A
P/S Ratio	0.08x	5.84x
EV/Sales	-0.47x	6.19x
EV/EBITDA	-58.64x	0.00x
P/B Ratio	0.02x	5.44x
P/FCF Ratio	6.75x	N/A
EV/FCF	-37.80x	-23.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	1.40x	N/A
Forward P/S (NTM)	0.07x	5.02x
Revenue & Growth
Revenue (TTM)	$432M	$37M
Revenue Growth (YoY)	26.1%	8.6%
Forward Rev Growth	0.0%	13.6%
Profitability
Gross Margin (TTM)	76.6%	71.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	1.2%	-28.3%
Net Margin (TTM)	-1.3%	-48.9%
FCF Margin (TTM)	1.2%	-26.0%
Net Income (TTM)	$-6M	$-18M
FCF (TTM)	$5M	$-10M
EPS (TTM)	-$0.11	-$0.29
ROE (TTM)	-88.0%	-16513.0%
ROA (TTM)	-77.0%	-4325.0%
ROIC (TTM)	-88.0%	-5193.0%
Financial Health
Cash	$239M	$4M
Debt	$0	$17M
Net Cash/Debt	$239M	$-13M
Current Ratio (TTM)	8.16x	0.66x
Quick Ratio (TTM)	6.33x	0.47x
Debt/Equity (TTM)	0.00x	7.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.24	1.51
52W Performance	-98.8%	-81.1%
YTD Performance	-0.1%	-73.6%
% from 52W High	-99.0%	-82.5%
% from 52W Low	1.4%	1.1%
Efficiency & Yields
Asset Turnover (TTM)	0.58x	0.88x
FCF Yield (TTM)	14.8%	-4.5%
Earnings Yield (TTM)	-15.6%	-8.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	27.3	-17.4
EV/GP/RG	N/A	0.53
Ticker research	View AXNX research	View CTSO research

Valuation

P/S Ratio

AXNX

0.08x

CTSO

5.84x

EV/FCF

AXNX

-37.80x

CTSO

-23.75x

Growth & revenue

Revenue Growth TTM

AXNX

26.1%

CTSO

8.6%

Forward Revenue Growth

CTSO

13.6%

AXNX

0.0%

Profitability & performance

Gross Margin

AXNX

76.6%

CTSO

71.6%

ROE

AXNX

-88.0%

CTSO

-16513.0%

FCF Yield %

AXNX

14.8%

CTSO

-4.5%

52-Week Performance

CTSO

-81.1%

AXNX

-98.8%

Detailed metrics comparison

AXNX

Axonics Inc

CTSO

Cytosorbents Corp

Market Cap

AXNX$36M

CTSO$217M

Enterprise Value

AXNX$-203M

CTSO$230M

Price

AXNX$0.71

CTSO$3.46

P/E Ratio

AXNXN/A

CTSON/A

P/S Ratio

AXNX0.08x

CTSO5.84x

EV/Sales

AXNX-0.47x

CTSO6.19x

EV/EBITDA

AXNX-58.64x

CTSO0.00x

P/B Ratio

AXNX0.02x

CTSO5.44x

P/FCF Ratio

AXNX6.75x

CTSON/A

EV/FCF

AXNX-37.80x

CTSO-23.75x

PEG Ratio

AXNXN/A

CTSON/A

Forward P/E (NTM)

AXNX1.40x

CTSON/A

Forward P/S (NTM)

AXNX0.07x

CTSO5.02x

Revenue (TTM)

AXNX$432M

CTSO$37M

Revenue Growth (YoY)

AXNX26.1%

CTSO8.6%

Forward Rev Growth

AXNX0.0%

CTSO13.6%

Gross Margin (TTM)

AXNX76.6%

CTSO71.6%

Operating Margin (TTM)

AXNX0.0%

CTSO0.0%

EBITDA Margin (TTM)

AXNX1.2%

CTSO-28.3%

Net Margin (TTM)

AXNX-1.3%

CTSO-48.9%

FCF Margin (TTM)

AXNX1.2%

CTSO-26.0%

Net Income (TTM)

AXNX$-6M

CTSO$-18M

FCF (TTM)

AXNX$5M

CTSO$-10M

EPS (TTM)

AXNX-$0.11

CTSO-$0.29

ROE (TTM)

AXNX-88.0%

CTSO-16513.0%

ROA (TTM)

AXNX-77.0%

CTSO-4325.0%

ROIC (TTM)

AXNX-88.0%

CTSO-5193.0%

Cash

AXNX$239M

CTSO$4M

Debt

AXNX$0

CTSO$17M

Net Cash/Debt

AXNX$239M

CTSO$-13M

Current Ratio (TTM)

AXNX8.16x

CTSO0.66x

Quick Ratio (TTM)

AXNX6.33x

CTSO0.47x

Debt/Equity (TTM)

AXNX0.00x

CTSO7.73x

Debt/Assets (TTM)

AXNX0.0%

CTSO0.0%

Interest Coverage (TTM)

AXNXN/A

CTSON/A

Net Debt/EBITDA (TTM)

AXNX0.00x

CTSO0.00x

Beta

AXNX3.24

CTSO1.51

52W Performance

AXNX-98.8%

CTSO-81.1%

YTD Performance

AXNX-0.1%

CTSO-73.6%

% from 52W High

AXNX-99.0%

CTSO-82.5%

% from 52W Low

AXNX1.4%

CTSO1.1%

Asset Turnover (TTM)

AXNX0.58x

CTSO0.88x

FCF Yield (TTM)

AXNX14.8%

CTSO-4.5%

Earnings Yield (TTM)

AXNX-15.6%

CTSO-8.4%

Dividend Yield (TTM)

AXNXN/A

CTSON/A

Rule of 40

AXNX27.3

CTSO-17.4

EV/GP/RG

AXNXN/A

CTSO0.53

Ticker research

View AXNX research View CTSO research

Metric	AXNX Axonics Inc	CTSO Cytosorbents Corp
Market & Valuation
Market Cap	$36M	$217M
Enterprise Value	$-203M	$230M
Price	$0.71	$3.46
P/E Ratio	N/A	N/A
P/S Ratio	0.08x	5.84x
EV/Sales	-0.47x	6.19x
EV/EBITDA	-58.64x	0.00x
P/B Ratio	0.02x	5.44x
P/FCF Ratio	6.75x	N/A
EV/FCF	-37.80x	-23.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	1.40x	N/A
Forward P/S (NTM)	0.07x	5.02x
Revenue & Growth
Revenue (TTM)	$432M	$37M
Revenue Growth (YoY)	26.1%	8.6%
Forward Rev Growth	0.0%	13.6%
Profitability
Gross Margin (TTM)	76.6%	71.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	1.2%	-28.3%
Net Margin (TTM)	-1.3%	-48.9%
FCF Margin (TTM)	1.2%	-26.0%
Net Income (TTM)	$-6M	$-18M
FCF (TTM)	$5M	$-10M
EPS (TTM)	-$0.11	-$0.29
ROE (TTM)	-88.0%	-16513.0%
ROA (TTM)	-77.0%	-4325.0%
ROIC (TTM)	-88.0%	-5193.0%
Financial Health
Cash	$239M	$4M
Debt	$0	$17M
Net Cash/Debt	$239M	$-13M
Current Ratio (TTM)	8.16x	0.66x
Quick Ratio (TTM)	6.33x	0.47x
Debt/Equity (TTM)	0.00x	7.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.24	1.51
52W Performance	-98.8%	-81.1%
YTD Performance	-0.1%	-73.6%
% from 52W High	-99.0%	-82.5%
% from 52W Low	1.4%	1.1%
Efficiency & Yields
Asset Turnover (TTM)	0.58x	0.88x
FCF Yield (TTM)	14.8%	-4.5%
Earnings Yield (TTM)	-15.6%	-8.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	27.3	-17.4
EV/GP/RG	N/A	0.53
Ticker research	View AXNX research	View CTSO research